Haemonetics ROA 2006-2020 | HAE

Current and historical return on assets (ROA) values for Haemonetics (HAE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Haemonetics ROA for the three months ending June 30, 2020 was 11.93%.
Haemonetics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $0.10B $1.43B 7.49%
2020-03-31 $0.08B $1.27B 6.21%
2019-12-31 $0.08B $1.24B 6.45%
2019-09-30 $0.07B $1.19B 5.49%
2019-06-30 $0.05B $1.26B 3.98%
2019-03-31 $0.06B $1.28B 4.39%
2018-12-31 $0.05B $1.23B 3.70%
2018-09-30 $0.02B $1.27B 1.66%
2018-06-30 $0.02B $1.24B 1.74%
2018-03-31 $0.05B $1.24B 3.55%
2017-12-31 $-0.02B $1.31B -1.42%
2017-09-30 $0.00B $1.27B 0.32%
2017-06-30 $0.00B $1.25B 0.31%
2017-03-31 $-0.03B $1.24B -2.00%
2016-12-31 $0.02B $1.31B 1.21%
2016-09-30 $-0.06B $1.34B -4.37%
2016-06-30 $-0.07B $1.32B -4.82%
2016-03-31 $-0.06B $1.32B -4.00%
2015-12-31 $-0.05B $1.34B -3.46%
2015-09-30 $0.03B $1.42B 1.79%
2015-06-30 $0.02B $1.43B 1.36%
2015-03-31 $0.02B $1.49B 1.08%
2014-12-31 $0.03B $1.47B 1.95%
2014-09-30 $0.03B $1.48B 1.95%
2014-06-30 $0.04B $1.48B 2.62%
2014-03-31 $0.04B $1.51B 2.35%
2013-12-31 $0.04B $1.49B 2.57%
2013-09-30 $0.03B $1.48B 2.17%
2013-06-30 $0.02B $1.48B 1.50%
2013-03-31 $0.04B $1.46B 3.01%
2012-12-31 $0.05B $1.47B 3.78%
2012-09-30 $0.05B $1.46B 5.12%
2012-06-30 $0.06B $0.93B 6.84%
2012-03-31 $0.07B $0.91B 7.80%
2011-12-31 $0.07B $0.85B 8.34%
2011-09-30 $0.07B $0.82B 8.75%
2011-06-30 $0.08B $0.85B 9.85%
2011-03-31 $0.08B $0.83B 10.48%
2010-12-31 $0.06B $0.78B 8.46%
2010-09-30 $0.06B $0.74B 8.42%
2010-06-30 $0.06B $0.70B 8.07%
2010-03-31 $0.06B $0.76B 8.09%
2009-12-31 $0.07B $0.70B 9.86%
2009-09-30 $0.07B $0.71B 9.86%
2009-06-30 $0.06B $0.69B 9.82%
2009-03-31 $0.06B $0.65B 9.51%
2008-12-31 $0.06B $0.62B 9.67%
2008-09-30 $0.06B $0.60B 9.56%
2008-06-30 $0.05B $0.61B 9.09%
2008-03-31 $0.05B $0.61B 9.04%
2007-12-31 $0.06B $0.57B 10.24%
2007-09-30 $0.06B $0.55B 10.84%
2007-06-30 $0.05B $0.58B 9.02%
2007-03-31 $0.05B $0.57B 8.70%
2006-12-31 $0.05B $0.55B 8.27%
2006-09-30 $0.06B $0.56B 10.38%
2006-06-30 $0.07B $0.57B 12.55%
2006-03-31 $0.07B $0.55B 13.44%
2005-12-31 $0.06B $0.52B 12.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.045B $0.988B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00